Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers

<p>Abstract</p> <p>Background</p> <p>Although the prognosis for Lupus Nephritis (LN) has dramatically improved with aggressive immunosuppressive therapies, these drugs carry significant side effects. To improve the effectiveness of these drugs, biomarkers of renal flare...

Full description

Bibliographic Details
Main Authors: Birmingham Daniel J, Friedman Avner, Schugart Richard C, Budu-Grajdeanu Paula, Rovin Brad H
Format: Article
Language:English
Published: BMC 2010-05-01
Series:Theoretical Biology and Medical Modelling
Online Access:http://www.tbiomed.com/content/7/1/14
id doaj-a1078ba992bd4bad91f4603c544a5e2d
record_format Article
spelling doaj-a1078ba992bd4bad91f4603c544a5e2d2020-11-25T00:39:10ZengBMCTheoretical Biology and Medical Modelling1742-46822010-05-01711410.1186/1742-4682-7-14Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkersBirmingham Daniel JFriedman AvnerSchugart Richard CBudu-Grajdeanu PaulaRovin Brad H<p>Abstract</p> <p>Background</p> <p>Although the prognosis for Lupus Nephritis (LN) has dramatically improved with aggressive immunosuppressive therapies, these drugs carry significant side effects. To improve the effectiveness of these drugs, biomarkers of renal flare cycle could be used to detect the onset, severity, and responsiveness of kidney relapses, and to modify therapy accordingly. However, LN is a complex disease and individual biomarkers have so far not been sufficient to accurately describe disease activity. It has been postulated that biomarkers would be more informative if integrated into a pathogenic-based model of LN.</p> <p>Results</p> <p>This work is a first attempt to integrate human LN biomarkers data into a model of kidney inflammation. Our approach is based on a system of differential equations that capture, in a simplified way, the complexity of interactions underlying disease activity. Using this model, we have been able to fit clinical urine biomarkers data from individual patients and estimate patient-specific parameters to reproduce disease dynamics, and to better understand disease mechanisms. Furthermore, our simulations suggest that the model can be used to evaluate therapeutic strategies for individual patients, or a group of patients that share similar data patterns.</p> <p>Conclusions</p> <p>We show that effective combination of clinical data and physiologically based mathematical modeling may provide a basis for more comprehensive modeling and improved clinical care for LN patients.</p> http://www.tbiomed.com/content/7/1/14
collection DOAJ
language English
format Article
sources DOAJ
author Birmingham Daniel J
Friedman Avner
Schugart Richard C
Budu-Grajdeanu Paula
Rovin Brad H
spellingShingle Birmingham Daniel J
Friedman Avner
Schugart Richard C
Budu-Grajdeanu Paula
Rovin Brad H
Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers
Theoretical Biology and Medical Modelling
author_facet Birmingham Daniel J
Friedman Avner
Schugart Richard C
Budu-Grajdeanu Paula
Rovin Brad H
author_sort Birmingham Daniel J
title Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers
title_short Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers
title_full Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers
title_fullStr Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers
title_full_unstemmed Mathematical framework for human SLE Nephritis: disease dynamics and urine biomarkers
title_sort mathematical framework for human sle nephritis: disease dynamics and urine biomarkers
publisher BMC
series Theoretical Biology and Medical Modelling
issn 1742-4682
publishDate 2010-05-01
description <p>Abstract</p> <p>Background</p> <p>Although the prognosis for Lupus Nephritis (LN) has dramatically improved with aggressive immunosuppressive therapies, these drugs carry significant side effects. To improve the effectiveness of these drugs, biomarkers of renal flare cycle could be used to detect the onset, severity, and responsiveness of kidney relapses, and to modify therapy accordingly. However, LN is a complex disease and individual biomarkers have so far not been sufficient to accurately describe disease activity. It has been postulated that biomarkers would be more informative if integrated into a pathogenic-based model of LN.</p> <p>Results</p> <p>This work is a first attempt to integrate human LN biomarkers data into a model of kidney inflammation. Our approach is based on a system of differential equations that capture, in a simplified way, the complexity of interactions underlying disease activity. Using this model, we have been able to fit clinical urine biomarkers data from individual patients and estimate patient-specific parameters to reproduce disease dynamics, and to better understand disease mechanisms. Furthermore, our simulations suggest that the model can be used to evaluate therapeutic strategies for individual patients, or a group of patients that share similar data patterns.</p> <p>Conclusions</p> <p>We show that effective combination of clinical data and physiologically based mathematical modeling may provide a basis for more comprehensive modeling and improved clinical care for LN patients.</p>
url http://www.tbiomed.com/content/7/1/14
work_keys_str_mv AT birminghamdanielj mathematicalframeworkforhumanslenephritisdiseasedynamicsandurinebiomarkers
AT friedmanavner mathematicalframeworkforhumanslenephritisdiseasedynamicsandurinebiomarkers
AT schugartrichardc mathematicalframeworkforhumanslenephritisdiseasedynamicsandurinebiomarkers
AT budugrajdeanupaula mathematicalframeworkforhumanslenephritisdiseasedynamicsandurinebiomarkers
AT rovinbradh mathematicalframeworkforhumanslenephritisdiseasedynamicsandurinebiomarkers
_version_ 1725294824067694592